Key points are not available for this paper at this time.
To evaluate the efficacy and safety of 24-week cyclic administration of estetrol (E4) (15 mg)/drospirenone (DRSP) (3 mg) in Japanese patients with endometriosis.
Harada et al. (Sun,) studied this question.